BitMine Immersion Technologies, Inc. (BMNR) is a Las Vegas-based blockchain infrastructure company that has evolved into the world's largest corporate Ethereum treasury. The company holds more than 6 million ETH — roughly 4.9% of the token's circulating supply — alongside a smaller Bitcoin position, cash, marketable securities, and early-stage "moonshot" investments. Its total crypto and cash holdings were recently valued above $16 billion.
BitMine operates an asset-light, ETH-focused model centered on accumulating digital assets, generating yield through its institutional staking and validation platform (MAVAN), and offering ancillary mining, hosting, consulting, and equipment-leasing services. Investors closely follow BMNR because its share price functions largely as a leveraged proxy for Ethereum and, more broadly, for digital-asset market sentiment. The company completed an uplisting to the NYSE in April 2026 and counts a range of prominent institutional backers among its supporters. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the trailing 30 days, BMNR has pulled back sharply. After closing at $28.03 on September 24, 2026, the stock declined to $22.40 by October 23, 2026, a drop of roughly 20%. The move reversed much of the momentum built during a late-September rally that pushed shares to an intraday peak near $28.76.
The longer-term picture is more favorable. For the third quarter of 2026, BMNR gained roughly 99%, outperforming Ethereum's approximately 71% advance over the same period. The stock climbed from a June 2026 low near $12.80 to its September high before the recent correction. This means the last month's decline represents a sharp short-term pullback within a still-strong multi-month uptrend, rather than a full reversal of the quarterly move. From what I see, this context matters when assessing whether the recent weakness signals a deeper trend shift.
The dominant driver was the decline in Ethereum itself. Ether fell roughly 10% in October, slipping from around $2,700 toward the $2,400 level, and remained down about 18% year to date. Because BMNR's valuation is tied directly to the value of its ETH holdings, weakness in the token translated into pressure on the stock.
A company-specific catalyst amplified the selling. At the TOKEN2049 conference on October 7, Chairman Tom Lee announced that BitMine will halt its Ether purchases once its treasury reaches 5% of the token's circulating supply. The shares dropped about 5% on the news, as investors reassessed a core element of the company's narrative: BitMine's role as a consistent, recurring buyer of Ether. Removing that demand was seen as removing a support both for ETH and for the stock's premium valuation.
Broader market conditions added to the pressure. U.S. spot Ether ETFs recorded roughly $1.08 billion in net outflows in October, erasing September's inflows. Risk assets were also weighed down by rising Treasury yields, a stronger U.S. dollar, elevated oil prices, and hotter-than-expected inflation readings, while leveraged long positions in Ether were liquidated during the decline. BitMine's ETH treasury also carried an estimated multi-billion-dollar unrealized loss, with the token trading below its roughly $3,300 average acquisition cost. I’m watching this closely as macro factors continue to influence sentiment.
BitMine's quarterly outperformance was driven by a sharp rally in Ethereum during the third quarter and by the company's aggressive accumulation strategy. As ETH advanced, the value of BitMine's growing treasury expanded, and the stock's premium to its underlying holdings widened, creating a self-reinforcing dynamic in which share issuance funded further Ether purchases.
Company-specific actions also supported the stock. BitMine executed the largest corporate buyback program in the crypto industry, repurchasing roughly 21 million shares during 2026 for more than $550 million, according to statements from management. The April NYSE uplisting improved the stock's profile and liquidity. These factors helped BMNR outperform both Ethereum and several peer treasury operators through September, before the October pullback narrowed that gap.
The most important variable for BMNR remains the price of Ethereum. Sustained weakness in ETH, continued ETF outflows, or further liquidation of leveraged positions would likely keep pressure on the stock, while a stabilization or recovery in the token could support a rebound. Investors should also watch how BitMine deploys capital after it reaches its 5% supply target, and whether staking revenue from MAVAN scales enough to offset the end of the accumulation program.
Additional factors include BitMine's next earnings report, estimated for November 20, 2026, along with any updates on share issuance under its shelf and at-the-market programs, which have contributed to significant expansion in the share count. Macroeconomic conditions — interest rates, the U.S. dollar, and risk appetite — will also influence digital-asset valuations. Analysts tracked by TipRanks have maintained a Moderate Buy consensus on BMNR with an average 12-month price target of $48.80, though such targets are subject to revision as market conditions evolve. As with any highly volatile, crypto-correlated equity, the stock's risk profile is elevated.
In my research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals for additional data-driven perspectives on names like this. The platform helps surface patterns and signals across thousands of tickers, which I find useful when cross-checking my own views on volatile sectors. It’s one more layer that complements traditional analysis without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
BMNR saw its Momentum Indicator move below the 0 level on October 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 126 similar instances where the indicator turned negative. In 123 of the 126 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BMNR turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 65 similar instances when the indicator turned negative. In 60 of the 65 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
BMNR moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BMNR crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMNR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for BMNR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMNR's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 69 cases where BMNR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The 50-day moving average for BMNR moved above the 200-day moving average on September 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +11.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMNR advanced for three days, in 93 of 134 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
BMNR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. BMNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.165) is normal, around the industry mean (3.517). P/E Ratio (-5.221) is within average values for comparable stocks, (8.810). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.002) settles around the average of (7.656) among similar stocks. BMNR's P/S Ratio (133.333) is slightly higher than the industry average of (16.763).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers